Advertisement

Current Treatment Options in Neurology

, Volume 4, Issue 1, pp 43–57 | Cite as

Cognitive impairment following traumatic brain injury

  • David B. Arciniegas
  • Kerri Held
  • Peter Wagner
Article

Opinion statement

  • Cognitive impairments due to traumatic brain injury (TBI) are substantial sources of morbidity for affected individuals, their family members, and society. Disturbances of attention, memory, and executive functioning are the most common neurocognitive consequences of TBI at all levels of severity. Disturbances of attention and memory are particularly problematic, as disruption of these relatively basic cognitive functions may cause or exacerbate additional disturbances in executive function, communication, and other relatively more complex cognitive functions.

  • Because of the high rate of other physical, neurologic, and psychiatric syndromes following TBI, a thorough neuropsychiatric assessment of the patient is a prerequisite to the prescription of any treatment for impaired cognition.

  • Psychostimulants and other dopaminergically active agents (eg, methylphenidate, dextroamphetamine, amantadine, levodopa/carbidopa, bromocriptine) may modestly improve arousal and speed of information processing, reduce distractibility, and improve some aspects of executive function.

  • Cautious dosing (start-low and go-slow), frequent standardized assessment of effects and side effects, and monitoring for drug-drug interactions are recommended.

  • Cognitive rehabilitation is useful for the treatment of memory impairments following TBI. Cognitive rehabilitation may also be useful for the treatment of impaired attention, interpersonal communication skills, and executive function following TBI. This form of treatment is most useful for patients with mild to moderate cognitive impairments, and may be particularly useful for those who are still relatively functionally independent and motivated to engage in and rehearse these strategies.

  • Psychotherapy (eg, supportive, individual, cognitive-behavioral, group, and family) is an important component of treatment. For patients with medication- and rehabilitation-refractory cognitive impairments, psychotherapy may be needed to assist both patients and families with adjustment to permanent disability.

Keywords

Traumatic Brain Injury Methylphenidate Amantadine Main Drug Interaction Mild Traumatic Brain Injury 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Kraus JF, Sorenson SB: Epidemiology. In Neuropsychiatry of Traumatic Brain Injury. Edited by Silver JM, Yudofsky SC, Hales RE. Washington, DC: American Psychiatric Press; 1994:3–41.Google Scholar
  2. 2.
    Waxweiler RJ, Thurman D, Sniezek J, et al.: Monitoring the impact of traumatic brain injury: a review and update. J Neurotrauma 1995, 12:509–516.PubMedGoogle Scholar
  3. 3.
    Fife D: Head injury with and without hospital admission: comparison of incidence and short-term disability. Am J Public Health 1987, 77:810–812.PubMedGoogle Scholar
  4. 4.
    Miller NS: Alcohol and Drug Disorders. In Neuropsychiatry of Traumatic Brain Injury. Edited by Silver JM, Yudosfsky SC, Hales RE. Washington, DC: American Psychiatric Press; 1994:471–512.Google Scholar
  5. 5.
    Fogel BS, Duffy J: Elderly Patients. In Neuropsychiatry of Traumatic Brain Injury. Edited by Silver JM, Yudofsky SC, Hales RE. Washington, DC: American Psychiatric Press; 1994:413–441.Google Scholar
  6. 6.
    Kraus JF, Nourjah P: The epidemiology of mild head injury. In Mild Head Injury. Edited by Levin HS, Eisenberg HM, Benton AL. New York: Oxford University Press; 1989:8–22.Google Scholar
  7. 7.
    McAllister TW: Neuropsychiatric sequelae of head injuries. Psychiat Clin N Am 1992, 15:395–413.Google Scholar
  8. 8.
    Max W, MacKenzie E, Rice D: Head injuries: costs and consequences. J Head Trauma Rehabil 1991, 6:76–91.Google Scholar
  9. 9.
    O’Shanick GJ, O’Shanick AM: Personality and Intellectual Changes. In Neuropsychiatry of Traumatic Brain Injury. Edited by Silver JM, Yudofsky SC, Hales RE. Washington, D.C.: American Psychiatric Press, Inc.; 1994:163–188.Google Scholar
  10. 10.
    Lovell MR, Franzen MD: Neuropsychological Assessment. In In Neuropsychiatry of Traumatic Brain Injury. Edited by Silver JM, Yudofsky SC, Hales RE. Washington, D.C.: American Psychiatric Press, Inc.; 1994:133–160.Google Scholar
  11. 11.
    Mesulam M-M: Principles of Behavioral and Cognitive Neurology, edn 2. Philadelphia: FA Davis; 2000.Google Scholar
  12. 12.
    Mega MS, Cummings JL: Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiat Clin Neurosci 1994, 6:358–370.Google Scholar
  13. 13.
    Spikman JM, Deelman BG, Van Zomeren AH: Executive functioning, attention and frontal lesions in patients with chronic CHI. J Clin Exp Neuropsychol 2000, 22:325–338.PubMedCrossRefGoogle Scholar
  14. 14.
    Silver JM, Yudofsky SC: Aggressive Disorders. In Neuropsychiatry of Traumatic Brain Injury. Edited by: Silver JM, Yudosfky SC, Hales RE. Washington, DC: American Psychiatric Press; 1994:313–353.Google Scholar
  15. 15.
    Arciniegas DB, Topkoff J, Silver JM: Neuropsychiatric Aspects of Traumatic Brain Injury. Curr Treat Options Neurol 2000, 2:167–186.Google Scholar
  16. 16.
    Campbell JJ, Duffy JD: Treatment strategies in amotivated patients. Psychiatr Ann 1997, 27:44–49.Google Scholar
  17. 17.
    Cassidy JW: Neuropathology. In Neuropsychiatry of Traumatic Brain Injury. Edited by Silver JM, Yudofsky SC, Hales RE. Washington, DC: American Psychiatric Press; 1994:43–79.Google Scholar
  18. 18.
    McIntosh TK, Juhler M, Raghupathi R, et al.: Secondary brain injury: neurochemical and cellular mediators. In Traumatic Brain Injury. Edited by Marion DW. New York: Thieme Medical Publishers; 1999:39–54.Google Scholar
  19. 19.
    Halliday AL: Pathophysiology. In Traumatic Brain Injury. Edited by Marion DW. New York: Thieme Medical Publishers; 1999:29–38.Google Scholar
  20. 20.
    Tang YP, Noda Y, Nabeshima T: Involvement of activation of dopaminergic neuronal system in learning and memory deficits associated with experimental mild traumatic brain injury. Euro J Neurosci 1997, 9:1720–1727.CrossRefGoogle Scholar
  21. 21.
    Eghwrudjakpor PO, Miyake H, Kurisaka M, Mori K: Central nervous system bioaminergic responses to mechanical trauma: an experimental study. Surg Neurol 1991, 35:273–279.PubMedCrossRefGoogle Scholar
  22. 22.
    Kmeciak-Kolada K, Felinska W, Stachura Z, et al.: Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussion. Pol J Pharmacol Pharm 1987, 39:47–53.Google Scholar
  23. 23.
    Donnemiller E, Brenneis C, Wissel J, et al.: Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPECT study using 123I-beta-CIT and 123I-IBZM. Eur J Nuclear Med 2000, 27:1410–1414.CrossRefGoogle Scholar
  24. 24.
    Hamill RW, Woolf PD, McDonald JV, et al.: Catecholamines predict outcome in traumatic brain injury. Ann Neurol 1987, 21:438–443.PubMedCrossRefGoogle Scholar
  25. 25.
    Woolf PD, Hamill RW, Lee LA, et al.: The predictive value of catecholamines in assessing outcome in traumatic brain injury. J Neurosurg 1987, 66:875–882.PubMedGoogle Scholar
  26. 26.
    Dixon CE, Bao J, Bergmann JS, Johnson KM: Traumatic brain injury reduces hippocampal high-affinity [3H]choline uptake but not extracellular choline levels in rats. Neurosci Letters 1994, 180:127–130.CrossRefGoogle Scholar
  27. 27.
    Saija A, Robinson SE, Lyeth BG, et al.: The effects of scopolamine and traumatic brain injury on central cholinergic neurons. J Neurotrauma 1988, 5:161–170.PubMedGoogle Scholar
  28. 28.
    DeAngelis MM, Hayes RL, Lyeth BG: Traumatic brain injury causes a decrease in M2 muscarinic cholinergic receptor binding in the rat brain. Brain Res 1994, 653:39–44.PubMedCrossRefGoogle Scholar
  29. 29.
    Murdoch I, Perry EK, Court JA, et al.: Cortical cholinergic dysfunction after human head injury. J Neurotrauma 1998, 15:295–305.PubMedGoogle Scholar
  30. 30.
    Dewar D, Graham DI: Depletion of choline acetyltransferase but preservation of M1 and M2 muscarinic receptor binding sites in temporal cortex following head injury: a preliminary human postmortem study. J Neurotrauma 1996, 13:181–187.PubMedGoogle Scholar
  31. 31.
    Blokland A: Acetylcholine: a neurotransmitter for learning and memory? Brain Res Brain Res Rev 1995, 21:285–300.PubMedCrossRefGoogle Scholar
  32. 32.
    Aigner TG: Pharmacology of memory: cholinergic-glutamatergic interactions. Curr Opin Neurobiol 1995, 5:155–160.PubMedCrossRefGoogle Scholar
  33. 33.
    Bogdanovitch UJ, Bazarevitch GJ, Kirillov AL: The use of cholinesterase in severe head injury. Resuscitation 1975, 4:139–141.PubMedCrossRefGoogle Scholar
  34. 34.
    Eames P, Sutton A: Protracted post-traumatic confusional state treated with physostigmine. Brain Inj 1995, 9:729–734.PubMedGoogle Scholar
  35. 35.
    Goldberg E, Gerstman LJ, Hughes JE, et al.: Selective effects of cholinergic treatment on verbal memory in posttraumatic amnesia. J Clin Neuropsychol 1982, 4:219–234.PubMedGoogle Scholar
  36. 36.
    Levin HS, Peters BH, Kalisky Z, et al.: Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients. Cent Nerv Sys Trauma 1986, 3:333–342.Google Scholar
  37. 37.
    Cardenas DD, McLean A, Farrell-Roberts L, et al.: Oral physostigmine and impaired memory in adults with brain injury. Brain Inj 1994, 8:579–587.PubMedGoogle Scholar
  38. 38.
    Taverni JP, Seliger G, Lichtman SW: Donepezil mediated memory improvement in traumatic brain injury during post acute rehabilitation. Brain Inj 1998, 12:77–80.PubMedCrossRefGoogle Scholar
  39. 39.
    Whelan FJ, Walker MS, Schultz SK: Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury. Ann Clin Psych 2000, 12:131–135. This article is describes the largest study of donepezil for the treatment of the neuropsychiatric sequelae of TBI performed to-date, and offers evidence to support use of this medication in this population.CrossRefGoogle Scholar
  40. 40.
    Speech TJ, Rao SM, Osmon DC, Sperry LT: A doubleblind controlled study of methylphenidate treatment in closed head injury. Brain Inj 1993, 7:333–338.PubMedGoogle Scholar
  41. 41.
    Plenger PM, Dixon CE, Castillo RM, et al.: Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehab 1996, 77:536–40.CrossRefGoogle Scholar
  42. 42.
    Kaelin DL, Cifu DX, Matthies B: Methylphenidate effect on attention deficit in the acutely brain-injured adult. Arch Phys Med Rehab 1996, 77:6–9. This study provides strong evidence of a beneficial effect of methylphenidate on several measures of attention.CrossRefGoogle Scholar
  43. 43.
    Gualtieri CT, Evans RW: Stimulant treatment for the neurobehavioral sequelae of traumatic brain injury. Brain Inj 1988, 2:273–290.PubMedGoogle Scholar
  44. 44.
    Whyte J, Hart T, Schuster K, et al.: Effects of methylphenidate on attentional function after traumatic brain injury. A randomized, placebocontrolled trial. Am J Phys Med Rehab 1997, 76:440–450. This excellent Class I study suggests that the primary benefits afforded by methylphenidate in cognitively impaired TBI survivors are increased arousal and improved processing speed.CrossRefGoogle Scholar
  45. 45.
    Wroblewski BA, Leary JM, Phelan AM, et al.: Methylphenidate and seizure frequency in brain injured patients with seizure disorders. J Clin Psych 1992, 53:86–89. Although now nearly a decade old, this article offers evidence that methylphenidate does not increase risk of seizures in this population.Google Scholar
  46. 46.
    Speech TJ, Rao SM, Osmon DC, Sperry LT: A doubleblind controlled study of methylphenidate treatment in closed head injury. Brain Inj 1993, 7:333–338.PubMedGoogle Scholar
  47. 47.
    Wroblewski BA, Leary JM, Phelan AM, et al.: Methylphenidate and seizure frequency in brain injured patients with seizure disorders. J Clin Psych 1992, 53:86–89.Google Scholar
  48. 48.
    Evans RW, Gualtieri CT, Patterson D: Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure. J Nerv Ment Dis 1987, 175:106–110.PubMedCrossRefGoogle Scholar
  49. 49.
    Gualtieri T, Chandler M, Coons TB, Brown LT: Amantadine: a new clinical profile for traumatic brain injury. Clin Neuropharmacol 1989, 12:258–270.PubMedCrossRefGoogle Scholar
  50. 50.
    Kraus MF, Maki PM: Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review. J Neuropsych Clin Neurosci 1997, 9:222–230.Google Scholar
  51. 51.
    Van Reekum R, Bayley M, Garner S, et al.: N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. Brain Inj 1995, 9:49–53.PubMedGoogle Scholar
  52. 52.
    Nickels JL, Schneider WN, Dombovy ML, Wong TM: Clinical use of amantadine in brain injury rehabilitation. Brain Inj 1994, 8:709–718.PubMedGoogle Scholar
  53. 53.
    McDowell S, Whyte J, D’Esposito M: Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 1998, 121:1155–1164.PubMedCrossRefGoogle Scholar
  54. 54.
    Lal S, Merbtiz CP, Grip JC: Modification of function in head-injured patients with Sinemet. Brain Inj 1988, 2:225–233.PubMedGoogle Scholar
  55. 55.
    Arciniegas D, Adler L, Topkoff J, et al.: Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Inj 1999, 13:1–13.PubMedCrossRefGoogle Scholar
  56. 56.
    Whitlock JA: Brain injury, cognitive impairment, and donepezil. J Head Trauma Rehab 1999, 1:424–427.Google Scholar
  57. 57.
    Arciniegas DB, Topkoff JL, Anderson CA, et al.: Normalization of P50 physiology by donepezil hydrochloride in traumatic brain injury patients. J Neuropsychiat Clin Neurosci 2001, 13:140.Google Scholar
  58. 58.
    Wroblewski B, Glenn MB, Cornblatt R, et al.: Protriptyline as an alternative stimulant medication in patients with brain injury: a series of case reports. Brain Inj 1993, 7:353–362.PubMedGoogle Scholar
  59. 59.
    Wroblewski BA, McColgan K, Smith K, et al.: The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population. J Clin Psychopharmacol 1990, 10:124–128.PubMedGoogle Scholar
  60. 60.
    Secades JJ, Frontera G: CDP-choline: pharmacological and clinical review. Methods Find Exp Clin Pharmacol 1995, 17(suppl):1–54. This article is one of the most frequently cited reviews of CDP-choline, and will be of particular use to those considering recommending this agent to their patients.PubMedGoogle Scholar
  61. 61.
    Dixon CE, Ma X, Marion DW: Effects of CDP-Choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. J Neurotrauma 1997, 14:161–169.PubMedGoogle Scholar
  62. 62.
    Calatayud M, Calatayud V, Perez JB, Aso EJ: Effects of CDP-choline on the recovery of patients with head injury. J Neurol Sci 1991, 103(suppl):S15-S18.CrossRefGoogle Scholar
  63. 63.
    Levin HS: Treatment of postconcussional symptoms with CDP-choline. J Neurol Sci 1991, 103:S39-S42.PubMedCrossRefGoogle Scholar
  64. 64.
    Fioravanti M, Yanagi M: Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. The Cochrane Database of Systematic Reviews 1[1]. 2001.Google Scholar
  65. 65.
    Pourcher E, Baruch P, Bouchard RH, et al.: Neuroleptic associated tardive dyskinesias in young people with psychoses. Brit J Psych 1995, 166:768–772.CrossRefGoogle Scholar
  66. 66.
    Stanislav SW: Cognitive effects of antipsychotic agents in persons with traumatic brain injury. Brain Inj 1997, 11:335–341.PubMedCrossRefGoogle Scholar
  67. 67.
    Smith KR, Jr, Goulding PM, Wilderman D, et al.: Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study. Arch Neurol 1994, 51:653–660.PubMedGoogle Scholar
  68. 68.
    Dikmen SS, Temkin NR, Miller B, et al.: Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA 1991, 265:1271–1277.PubMedCrossRefGoogle Scholar
  69. 69.
    Cicerone KD, Dahlberg C, Kalmar K, et al.: Evidencebased cognitive rehabilitation: recommendations for clinical practice. Arch Phys Med Rehab 2000, 81:1596–1615. This article reviews the literature regarding cognitive rehabilitation is substantial detail, and will be very useful for those wishing to quickly survey the literature regarding the effectiveness of cognitive rehabilitation for patients with TBI or stroke.CrossRefGoogle Scholar
  70. 70.
    Novack TA, Dillon MC, Jackson WT: Neurochemical mechanisms in brain injury and treatment: a review. J Clin Exp Neuropsychol 1996, 18:685–706.PubMedGoogle Scholar
  71. 71.
    Ponsford JL, Kinsella G: Evaluation of a remedial programme for attentional deficits following closed-head injury. J Clin Exp Neuropsychol 1988, 10:693–708.PubMedGoogle Scholar
  72. 72.
    Gray JM, Robertson I, Pentland B, Anderson S: Microcomputer-based attentional retraining after brain damage: a randomized group controlled trial. Neuropsychol Rehab 1992, 2:97–115.Google Scholar
  73. 73.
    Ethier M, Braun CM, Baribeau JM: Computer-dispensed cognitive-perceptual training of closed head injury patients after spontaneous recovery. Study 1: speeded tasks. Can J Rehabil 1989, 2:223–233.Google Scholar
  74. 74.
    Berg I, Konning-Haanstra M, Deelman B: Long-term effects of memory rehabilitation: a controlled study. Neuropsychol Rehab 1991, 1:97–111.Google Scholar
  75. 75.
    Ryan TV, Ruff RM: The efficacy of structured memory retraining in a group comparison of head trauma patients. Arch Clin Neuropsychol 1988, 3:165–179.PubMedCrossRefGoogle Scholar
  76. 76.
    Schmitter-Edgecombe M, Fahy J, Whelan J, Long C: Memory remediation after severe closed head injury. Notebook training versus supportive therapy. J Consult Clin Psychol 1995, 63:484–489.PubMedCrossRefGoogle Scholar
  77. 77.
    Wilson BA, Evans JJ, Emslie H, Malinek V: Evaluation of NeuroPage: a new memory aid. J Neurol Neurosurg Psychiatry 1997, 63:113–115.PubMedGoogle Scholar
  78. 78.
    Zencius A, Wesolowski MD, Burke WH: A comparison of four memory strategies with traumatically brain-injured clients. Brain Inj 1990, 4:33–38.PubMedGoogle Scholar
  79. 79.
    Burke JM, Danick JA, Bemis B, Durgin CJ: A process approach to memory book training for neurological patients. Brain Inj 1994, 8:71–81.PubMedGoogle Scholar
  80. 80.
    Kime SK, Lamb DG, Wilson BA: Use of a comprehensive programme of external cueing to enhance procedural memory in a patient with dense amnesia. Brain Inj 1996, 10:17–25.PubMedCrossRefGoogle Scholar
  81. 81.
    Helffenstein D, Wechsler R: The use of interpersonal process recall (IPR) in the remediation of interpersonal and communication skill deficits in the newly brain injured. Clin Neuropsychol 1982, 4:139–143.Google Scholar
  82. 82.
    Gajar A, Schloss PJ, Schloss CN, Thompson CK: Effects of feedback and self-monitoring on head trauma youths’ conversation skills. J Appl Behav Anal 1984, 17:353–358.PubMedCrossRefGoogle Scholar
  83. 83.
    Fox RM, Martella RC, Marchand-Martella NE: The acquisition, maintenance and generalization of problem solving skills by closed head injured adults. Behav Ther 1989, 20:61–76.CrossRefGoogle Scholar
  84. 84.
    Cicerone KD, Giacino JT: Remediation of executive function deficits after traumatic brain injury. Neurorehabilitation 1992, 2:12–22.Google Scholar
  85. 85.
    Sohlberg MM, Sprunk H, Metzelaar K: Efficacy of an external cueing system in an individual with severe frontal lobe damage. Cognit Rehab 1988, 6:36–41.Google Scholar
  86. 86.
    Evans JJ, Emslie H, Wilson BA: External cueing systems in the rehabilitation of executive impairments of action. J Int.Neuropsychol Soc 1998, 4:399–408.PubMedGoogle Scholar
  87. 87.
    Paniak C, Toller-Lobe G, Durand A, Nagy J: A randomized trial of two treatments for mild traumatic brain injury. Brain Inj 1998, 12:1011–1023.PubMedCrossRefGoogle Scholar
  88. 88.
    Lundgren CC, Persechino EL: Cognitive group: a treatment program for head-injured adults. Am J Occ Ther 1986, 40:397–401.Google Scholar
  89. 89.
    Uomoto JM, Brockway JA: Anger management training for brain injured patients and their family members. Arch Phys Med Rehab 1992, 73:674–679.Google Scholar
  90. 90.
    Miller LJ, Mittenberg W: Brief cognitive behavioral interventions in mild traumatic brain injury. App Neuropsychol 1998, 5:172–183.CrossRefGoogle Scholar

Copyright information

© Current Science Inc 2002

Authors and Affiliations

  • David B. Arciniegas
    • 1
  • Kerri Held
  • Peter Wagner
  1. 1.Denver Veterans Affairs Medical CenterDenverUSA

Personalised recommendations